ISEE Annual FCF
-$164.51 M
-$65.59 M-66.30%
31 December 2022
Summary:
As of February 5, 2025, ISEE annual free cash flow is -$164.51 million, with the most recent change of -$65.59 million (-66.30%) on December 31, 2022. During the last 3 years, it has fallen by -$116.02 million (-239.26%).ISEE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ISEE Quarterly FCF
-$50.83 M
-$1.30 M-2.62%
31 March 2023
Summary:
As of February 5, 2025, ISEE quarterly free cash flow is -$50.83 million, with the most recent change of -$1.30 million (-2.62%) on March 31, 2023. Over the past year, it has dropped by -$13.20 million (-35.07%).ISEE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ISEE TTM FCF
-$177.71 M
-$13.20 M-8.02%
31 March 2023
Summary:
As of February 5, 2025, ISEE TTM free cash flow is -$177.71 million, with the most recent change of -$13.20 million (-8.02%) on March 31, 2023. Over the past year, it has dropped by -$70.97 million (-66.50%).ISEE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ISEE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.3% | -35.1% | -66.5% |
| 3 y3 years | -239.3% | -190.0% | -245.6% |
| 5 y5 years | -35.0% | -320.5% | -266.5% |
ISEE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -250.3% | -131.6% | -262.4% |
IVERIC Bio Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$50.83 M(+2.6%) | -$177.71 M(+8.0%) |
| Dec 2022 | -$164.51 M(+66.3%) | -$49.53 M(+19.8%) | -$164.51 M(+19.7%) |
| Sept 2022 | - | -$41.34 M(+14.8%) | -$137.41 M(+12.4%) |
| June 2022 | - | -$36.00 M(-4.3%) | -$122.28 M(+14.6%) |
| Mar 2022 | - | -$37.63 M(+67.7%) | -$106.73 M(+8.3%) |
| Dec 2021 | -$98.92 M(+49.7%) | -$22.43 M(-14.4%) | -$98.56 M(+1.4%) |
| Sept 2021 | - | -$26.22 M(+28.2%) | -$97.19 M(+13.4%) |
| June 2021 | - | -$20.45 M(-30.6%) | -$85.73 M(+9.9%) |
| Mar 2021 | - | -$29.46 M(+39.8%) | -$78.03 M(+18.1%) |
| Dec 2020 | -$66.10 M(+36.3%) | -$21.07 M(+42.8%) | -$66.10 M(+16.1%) |
| Sept 2020 | - | -$14.76 M(+15.8%) | -$56.94 M(+4.7%) |
| June 2020 | - | -$12.74 M(-27.3%) | -$54.41 M(+5.8%) |
| Mar 2020 | - | -$17.53 M(+47.2%) | -$51.41 M(+6.0%) |
| Dec 2019 | -$48.49 M(+15.7%) | -$11.91 M(-2.6%) | -$48.49 M(+3.9%) |
| Sept 2019 | - | -$12.23 M(+25.4%) | -$46.66 M(+3.1%) |
| June 2019 | - | -$9.75 M(-33.2%) | -$45.26 M(+1.9%) |
| Mar 2019 | - | -$14.60 M(+44.8%) | -$44.43 M(+6.0%) |
| Dec 2018 | -$41.91 M(-65.6%) | -$10.08 M(-6.8%) | -$41.91 M(-7.0%) |
| Sept 2018 | - | -$10.82 M(+21.3%) | -$45.07 M(-10.4%) |
| June 2018 | - | -$8.92 M(-26.2%) | -$50.33 M(-30.5%) |
| Mar 2018 | - | -$12.09 M(-8.7%) | -$72.40 M(-40.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$121.82 M(+11.6%) | -$13.24 M(-17.6%) | -$121.82 M(-14.0%) |
| Sept 2017 | - | -$16.07 M(-48.1%) | -$141.71 M(+7.7%) |
| June 2017 | - | -$30.99 M(-49.6%) | -$131.56 M(-1.7%) |
| Mar 2017 | - | -$61.51 M(+85.6%) | -$133.88 M(+22.6%) |
| Dec 2016 | -$109.17 M(+34.5%) | -$33.14 M(+459.7%) | -$109.17 M(-6.0%) |
| Sept 2016 | - | -$5.92 M(-82.2%) | -$116.11 M(-13.9%) |
| June 2016 | - | -$33.31 M(-9.5%) | -$134.86 M(+56.1%) |
| Mar 2016 | - | -$36.80 M(-8.2%) | -$86.38 M(+6.4%) |
| Dec 2015 | -$81.15 M(-174.2%) | -$40.08 M(+62.4%) | -$81.15 M(+165.0%) |
| Sept 2015 | - | -$24.68 M(-262.6%) | -$30.62 M(-40.0%) |
| June 2015 | - | $15.18 M(-148.1%) | -$51.07 M(-153.9%) |
| Mar 2015 | - | -$31.57 M(-402.0%) | $94.73 M(-13.4%) |
| Dec 2014 | $109.43 M(-324.3%) | $10.45 M(-123.2%) | $109.43 M(+49.1%) |
| Sept 2014 | - | -$45.13 M(-128.0%) | $73.40 M(-30.6%) |
| June 2014 | - | $160.98 M(-1054.0%) | $105.76 M(-270.3%) |
| Mar 2014 | - | -$16.87 M(-34.0%) | -$62.12 M(+27.3%) |
| Dec 2013 | -$48.78 M(+272.3%) | -$25.58 M(+100.3%) | -$48.78 M(+110.2%) |
| Sept 2013 | - | -$12.77 M(+85.0%) | -$23.20 M(+122.4%) |
| June 2013 | - | -$6.90 M(+95.3%) | -$10.44 M(+195.3%) |
| Mar 2013 | - | -$3.53 M | -$3.53 M |
| Dec 2012 | -$13.10 M(-31.5%) | - | - |
| Dec 2011 | -$19.13 M | - | - |
FAQ
- What is IVERIC bio annual free cash flow?
- What is the all time high annual FCF for IVERIC bio?
- What is IVERIC bio annual FCF year-on-year change?
- What is IVERIC bio quarterly free cash flow?
- What is the all time high quarterly FCF for IVERIC bio?
- What is IVERIC bio quarterly FCF year-on-year change?
- What is IVERIC bio TTM free cash flow?
- What is the all time high TTM FCF for IVERIC bio?
- What is IVERIC bio TTM FCF year-on-year change?
What is IVERIC bio annual free cash flow?
The current annual FCF of ISEE is -$164.51 M
What is the all time high annual FCF for IVERIC bio?
IVERIC bio all-time high annual free cash flow is $109.43 M
What is IVERIC bio annual FCF year-on-year change?
Over the past year, ISEE annual free cash flow has changed by -$65.59 M (-66.30%)
What is IVERIC bio quarterly free cash flow?
The current quarterly FCF of ISEE is -$50.83 M
What is the all time high quarterly FCF for IVERIC bio?
IVERIC bio all-time high quarterly free cash flow is $160.98 M
What is IVERIC bio quarterly FCF year-on-year change?
Over the past year, ISEE quarterly free cash flow has changed by -$13.20 M (-35.07%)
What is IVERIC bio TTM free cash flow?
The current TTM FCF of ISEE is -$177.71 M
What is the all time high TTM FCF for IVERIC bio?
IVERIC bio all-time high TTM free cash flow is $109.43 M
What is IVERIC bio TTM FCF year-on-year change?
Over the past year, ISEE TTM free cash flow has changed by -$70.97 M (-66.50%)